Insider · CIK 0002069143
Carl Theobold Schultz
Files at MVST (Microvast Holdings, Inc.). First filing -, latest -.
Carl Theobold Schultz files SEC Form 4 as CFO at MVST (Microvast Holdings, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Carl Theobold Schultz has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 5, 2025 | MVST Microvast Holdings, Inc. | AGrant or award Common Stock | +35,000 | - | - | 70,000 | Jun 9, 2025 |
| Jun 2, 2025 | MVST Microvast Holdings, Inc. | AGrant or award Common Stock | +35,000 | - | - | 35,000 | Jun 3, 2025 |
| Jun 2, 2025 | MVST Microvast Holdings, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +300,000 | $0.00 | $0 | 300,000 | Jun 3, 2025 |
Questions about Carl Theobold Schultz
Answered from the filings on this page, as of the latest one.
Is Carl Theobold Schultz buying or selling?
Carl Theobold Schultz has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Carl Theobold Schultz's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Carl Theobold Schultz has 0.
Where does Carl Theobold Schultz file Form 4?
Carl Theobold Schultz has filed Form 4 at MVST (Microvast Holdings, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.